Document is current
Any future updates will be listed below
-
Authors
Nelsen, Linda M. https://orcid.org/0000-0002-3929-4064
Lee, Laurie A.
Wu, Wei
Lin, Xiwu
Murray, Lindsey
Pascoe, Steven J.
Leidy, Nancy K.
-
Funding
Funding for this research was provided by:
GSK (N/A)
- License Information
-
More Information
Article History
Received: 30 August 2018
Accepted: 13 May 2019
First Online: 31 May 2019
Ethics approval and consent to participate
: No ethics approval was required for this study as data were taken from a previously conducted clinical trial (GSK: 200699, NCT02164539) that had obtained ethical approval. []
: Not applicable.
: The authors met the criteria for authorship as recommended by the International Committee of Medical Journal Editors. LMN and LAL are employees of GSK and own stocks/shares in GSK. XL, WW and SJP were employees of GSK at the time the study was performed and own GSK stocks/shares. WW is currently employed by PAREXEL International. LM and NKL are employees of Evidera, which provides consulting and other research services to pharmaceutical, device, government and non-government organizations. Evidera holds the copyright to the EXACT, E-RS:COPD and all derivative measures. All authors were not paid for the development of this manuscript. Ellipta is owned by or licensed to the GSK group of companies.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
